Logo image of CTM

CASTELLUM INC (CTM) Stock Fundamental Analysis

NYSEARCA:CTM - NYSE Arca - US14838T2042 - Common Stock - Currency: USD

1.02  -0.02 (-1.92%)

After market: 1.02 0 (0%)

Fundamental Rating

2

Taking everything into account, CTM scores 2 out of 10 in our fundamental rating. CTM was compared to 82 industry peers in the IT Services industry. While CTM seems to be doing ok healthwise, there are quite some concerns on its profitability. CTM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTM had negative earnings in the past year.
CTM had a positive operating cash flow in the past year.
CTM had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CTM reported negative operating cash flow in multiple years.
CTM Yearly Net Income VS EBIT VS OCF VS FCFCTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

The Return On Assets of CTM (-26.69%) is worse than 79.27% of its industry peers.
Looking at the Return On Equity, with a value of -50.04%, CTM is doing worse than 73.17% of the companies in the same industry.
Industry RankSector Rank
ROA -26.69%
ROE -50.04%
ROIC N/A
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
CTM Yearly ROA, ROE, ROICCTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

CTM has a Gross Margin (40.80%) which is in line with its industry peers.
CTM's Gross Margin has declined in the last couple of years.
CTM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
CTM Yearly Profit, Operating, Gross MarginsCTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTM has been increased compared to 1 year ago.
CTM has a better debt/assets ratio than last year.
CTM Yearly Shares OutstandingCTM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
CTM Yearly Total Debt VS Total AssetsCTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 1.84 indicates that CTM is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CTM (1.84) is comparable to the rest of the industry.
CTM has a debt to FCF ratio of 9.40. This is a negative value and a sign of low solvency as CTM would need 9.40 years to pay back of all of its debts.
The Debt to FCF ratio of CTM (9.40) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.45 indicates that CTM is not too dependend on debt financing.
CTM's Debt to Equity ratio of 0.45 is in line compared to the rest of the industry. CTM outperforms 51.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 9.4
Altman-Z 1.84
ROIC/WACCN/A
WACC9.54%
CTM Yearly LT Debt VS Equity VS FCFCTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.92 indicates that CTM should not have too much problems paying its short term obligations.
The Current ratio of CTM (1.92) is better than 64.63% of its industry peers.
A Quick Ratio of 1.92 indicates that CTM should not have too much problems paying its short term obligations.
The Quick ratio of CTM (1.92) is better than 64.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.92
CTM Yearly Current Assets VS Current LiabilitesCTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

CTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.63%, which is quite impressive.
The Revenue has decreased by -1.06% in the past year.
CTM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.32% yearly.
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.69%
Revenue 1Y (TTM)-1.06%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%-7.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTM Yearly Revenue VS EstimatesCTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CTM Yearly EPS VS EstimatesCTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTM Price Earnings VS Forward Price EarningsCTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

CTM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 77.53
EV/EBITDA N/A
CTM Per share dataCTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTELLUM INC

NYSEARCA:CTM (5/20/2025, 8:04:01 PM)

After market: 1.02 0 (0%)

1.02

-0.02 (-1.92%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)05-20 2025-05-20
Inst Owners6.83%
Inst Owner Change-30.57%
Ins Owners18.97%
Ins Owner Change-5.28%
Market Cap86.59M
Analysts80
Price Target3.06 (200%)
Short Float %2.39%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)160.87%
PT rev (3m)160.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.93
P/FCF 77.53
P/OCF 77.3
P/B 4.29
P/tB 31.93
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY1.29%
OCF(TTM)0.01
OCFY1.29%
SpS0.53
BVpS0.24
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.69%
ROE -50.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.81%
FCFM 2.49%
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
F-Score5
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 9.4
Debt/EBITDA N/A
Cap/Depr 0.15%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.92
Altman-Z 1.84
F-Score5
WACC9.54%
ROIC/WACCN/A
Cap/Depr(3y)1.76%
Cap/Depr(5y)1.22%
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.06%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%-7.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.46%
OCF growth 3YN/A
OCF growth 5YN/A